Phase II Study of Pembrolizumab for Oligometastatic Non-Small Cell Lung Cancer (NSCLC) Following Completion of Locally Ablative Therapy (LAT)

JOURNAL OF THORACIC ONCOLOGY(2018)

引用 3|浏览21
暂无评分
关键词
Oligometastatic,pembrolizumab,locally ablative therapy
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要